Interstitial lung disease Clinical Trials
Recruiting interstitial lung disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat interstitial lung disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting interstitial lung disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting interstitial lung disease trials
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
Virtual Nurse and Social Worker Palliative Care Team to Improve Quality of Life in Veterans With Heart Failure or COPD
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis
Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia
Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment
Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment
Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
The Effect of Video Game-Based Exercise Training in Patients With Interstitial Lung Disease
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
MOBoxy: MoblO2 to Maintain Oxygenation
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
Evaluation of the Reproducibility of the Automated Measurement of the Extent of ILD on Chest CT
Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Continuous Versus Demand-Based Oxygen in Patients With Fibrotic Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound
Early Recognition of Progressive Lung Fibrosis in Systemic Rheumatic Diseases
P4O2 ILD Extension
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Qifangfeixian Granules in the Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD)
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease
ADSCs Therapy in Patients With CTD-ILD
Skeletal Muscle Function in Interstitial Lung Disease
Effects of Drinking Beetroot Juice on Exercise Performance in Patients With Fibrotic Interstitial Lung Disease
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
Patients With Interstitial Lung Disease
Taiwan Interstitial Lung Disease Multi-center Investigation and Registry
Interstitial Lung Disease Registry Study: Prospective and Retrospective Observational Study in Austria
Feasibility of Semaglutide in Advanced Lung Disease
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
129Xe MRI Cardiopulmonary
NIV Versus HFO for Acute Exacerbations of Interstitial Lung Diseases
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
CT Quantitative Assessment of Interstitial Lung Disease
Pulmonary Hypertension SOLAR
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis
Interstitial lung disease clinical trials — common questions
Are interstitial lung disease clinical trials free to join?
Yes. Participating in a interstitial lung disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a interstitial lung disease clinical trial?
Each interstitial lung disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a interstitial lung disease trial near me?
Use the location controls above. We'll show recruiting interstitial lung disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many interstitial lung disease trials are recruiting right now?
We're currently tracking roughly 35 recruiting interstitial lung disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.